TS-005663 — This new method builds upon previous HR templates for correcting CFTR mutations. This invention combines HMEJ templates with DNA-repair inhibitors to improve gene insertion further. Combining HMEJ templates and DNA repair inhibitors during gene editing has shown more efficient CFTR cDNA replacement, which could be utilized in both in vivo and ex vivo therapies for people with cystic fibrosis (CF).